Rare Diseases

Latest News

5 Pending FDA Decisions in Neurology to Look for in 2023
5 Pending FDA Decisions in Neurology to Look for in 2023

January 27th 2023

Take a look at 5 of the most-anticipated FDA pending approvals expected in 2023 that neurological researchers and clinicians should keep an eye out on.

Treatment Disparities, Neurologic Complications Clarified by COVID-19 Neurological Research
Treatment Disparities, Neurologic Complications Clarified by COVID-19 Neurological Research

April 19th 2021

Out-of-Pocket Costs Steadily Increasing for Neurologic Care
Out-of-Pocket Costs Steadily Increasing for Neurologic Care

January 5th 2021

MOVE-FA Study Initiated for Friedriech’s Ataxia in Children and Young Adults
MOVE-FA Study Initiated for Friedriech’s Ataxia in Children and Young Adults

December 23rd 2020

Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis
Initial Results Prove Positive for Low-Dose AXO-AAV-GM1 in GM1 Gangliosidosis

December 16th 2020

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.